Caribou Biosciences
CRBU
131 hedge funds and large institutions have $46.5M invested in Caribou Biosciences in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 42 reducing their positions, and 19 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
36% more call options, than puts
Call options by funds: $136K | Put options by funds: $100K
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
2% less funds holding
Funds holding: 133 → 131 (-2)
10.32% less ownership
Funds ownership: 64.35% → 54.03% (-10%)
17% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 42
50% less capital invested
Capital invested by funds: $93.1M → $46.5M (-$46.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$1.12M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$796K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$602K |
| 4 |
GAA
Green Alpha Advisors
Niwot,
Colorado
|
+$327K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$310K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.95M |
| 2 |
JP Morgan Chase
New York
|
-$2.2M |
| 3 |
EWM
Elmwood Wealth Management
Berkeley,
California
|
-$2.02M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.78M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$1.37M |
CRBU Hedge Fund Activity: Q1 2025 in Review
131 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q1 2025, worth a combined $46.5M — down 50% from $93.1M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CRBU and 18 opened new positions — a net loss of 1 holder — while 42 trimmed existing stakes and 35 added.
The largest buyer was Kynam Capital Management, adding an estimated $1.12M. The largest seller was Morgan Stanley, cutting an estimated $2.95M.
- 131 institutional investors held Caribou Biosciences (CRBU) as of Q1 2025, down from 133 in Q4 2024.
- Funds reported $46.5M of Caribou Biosciences stock for Q1 2025, down 50% quarter-over-quarter.
- 18 funds opened new Caribou Biosciences positions in Q1 2025 and 19 closed out, a net change of -1 holder.
- The largest Caribou Biosciences buyer in Q1 2025 was Kynam Capital Management, an estimated $1.12M added.
- The largest Caribou Biosciences seller in Q1 2025 was Morgan Stanley, an estimated $2.95M sold.
Based on aggregated 13F filings for Q1 2025.